Phase II Fludarabine, Cytoxan and FCCAM in Untreated B-Cell Chronic Lymphocytic Leukemia
This study has been completed.
Sponsor:
Steven E. Coutre
Collaborator:
Bayer
Information provided by (Responsible Party):
Steven E. Coutre, Stanford University
ClinicalTrials.gov Identifier:
NCT00230282
First received: September 28, 2005
Last updated: June 29, 2012
Last verified: June 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | October 2011 |
| Primary Completion Date: | December 2010 (Final data collection date for primary outcome measure) |